Analysis of real and hypothetical data demonstrates its applications beyond binary tests. It works even when the conventional methods of dichotomization and ROC curve analysis fail.
'Sensitivity' (Se) and 'specificity' (Sp) are the two basic measures which characterize the performance of a diagnostic or screening test. 1 The Se is the probability of a diseased subject having a positive test result, while the Sp is the probability of a negative response for a disease-free subject. A test with high Se implies that it is 'sensitive' in detecting the disease. Whereas a test with high Sp restricts the number of subjects without disease testing positive, thereby rendering it 'specific' to the actual disease.
There is an alternative but no less important way by which to look upon a sensitive or a specific test. [1] [2] [3] If a test is sensitive, most of the diseased subjects will be defined as positive after testing. Thus a negative response effectively 'rules out' the target disorder: the 'rule out-sensitive test' principle. Whereas with a specific test, a positive response makes the presence of disease more likely, since it is specific (though not exclusively) to the disease: the 'rule in-specific test' principle. The rule-out principle is useful when there is an important penalty for missing a disease, such as in screening for a potentially fatal disease with a fairly safe treatment (e.g. hypothyroidism, tuberculosis, etc.). It is also useful in reducing the number of possible diagnoses to be considered in early stages of diagnostic workup. The rule-in principle is usefully applied when confirming a diagnosis suggested by other data, or when a highly toxic treatment (e.g. combination chemotherapy for malignancies) is to be initiated once the diagnosis is established.
Recently, the likelihood ratio (LR) has been advocated for use in ruling in or ruling out disease as well. 4 The LR at test result t (denoted as LR t ) is defined as the ratio of the probability of having test result t for a diseased subject to the corresponding probability for a non-diseased subject. 5 The LR provides information on the at-risk status. The greater the LR value at test result t, the greater the risk of having the disease for those tested at t. 5 For a binary test with test results of positive (+) and negative (-), we have by definition, LR + = Se/(1 -Sp) and LR -= (1 -Se)/Sp. Thus, the rule-in potential of a positive test result can be characterized by LR + . And for a negative result, its rule-out potential is LR -. 4 The above discussion pertains only to a binary diagnostic test (e.g. positivity/negativity of a VDRL test, presence/absence of a Barbinski sign). We note that, however, diagnostic tests are not always black-and-white. Many tests are in an ordinal scale. For example, the computerized tomographic analysis of a brain lesion may be classified as hypodensity, normodensity, and hyperdensity. And the rating of a particular cytological specimen may be on a five-category scale of definitely normal, probably normal,
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Background To select a proper diagnostic test, it is recommended that the most specific test be used to confirm (rule in) a diagnosis, and the most sensitive test be used to establish that a disease is unlikely (rule out). These rule-in and rule-out concepts can also be characterized by the likelihood ratio (LR). However, previous papers discussed only the case of binary tests and assumed test results already known.
Methods
The author proposes using the 'Kullback-Leibler distance' as a new measure of rule-in/out potential. The Kullback-Leibler distance is an abstract concept arising from statistics and information theory. The author shows that it integrates in a proper way two sources of information-the distribution of test outcomes and the LR function. The index predicts the fate of an average subject before testing. We unfortunately still don't know how an average subject will turn out, before the test is administered.
In this paper, we use the 'Kullback-Leibler distance' 6,7 to characterize the 'before-test' potentials of ruling out and ruling in a disease. The application is not limited to a binary diagnostic test. Real and hypothetical data will be used for illustration.
The Kullback-Leibler distance
The Kullback-Leibler distance (also called 'divergence', 'information number', or 'relative entropy') is an abstract concept arising from statistics and information theory. 6, 7 It measures the 'distance' or 'separation' between two probability distributions. To our knowledge, it has not been used before for the purpose of characterizing the performances of diagnostic tests.
To begin with, consider an ordinal diagnostic test. Let the test results be indexed by i, i = 1,2,…, K. The proportions of the diseased subjects and the disease-free in the ith testing category are assumed known and are denoted as f i and g i , respectively
). That is, f i = Pr(test result is i amongst diseased subjects) and g i = Pr (test result is i amongst the disease-free). The LR function for this test is LR i = f i /g i . The Kullback-Leibler distance measures the distance between the diseased and the disease-free distributions (the f and the g distributions). Using the disease-free distribution as the reference, the KullbackLeibler distance (denoted as D( f || g)) is defined by the following equation:
Note that the above-defined Kullback-Leibler distance is always non-negative, with a larger value indicating greater separation in the two distributions. 6, 7 It is zero if and only if the diseased and the disease-free subjects are identically distributed according to the diagnostic test. 6, 7 The Kullback-Leibler distance is not symmetric. 6, 7 The distance depends on which distributionthe diseased or the disease-free-is taken as the reference. The Kullback-Leibler distance, using the diseased distribution instead as the reference
For a binary diagnostic test (K = 2), the above equations also apply and become: D( f || g) for binary tests and D( g || f ) for binary tests As for diagnostic tests with values in a continuous scale, the Kullback-Leibler distance can also be defined. 6, 7 We do not present the formula here, since the mathematics are more complex. For practical purposes, one can categorize a continuous test into an ordinal one, and apply the equations above.
Ruling in and ruling out disease
It is of interest to note that the Kullback-Leibler distances of D( f || g) and D( g || f ) can be interpreted as the before-test potentials of ruling in and ruling out disease, respectively.
Let
]. The Appendix shows that P in is the ratio, for a randomly selected diseased subject, of the post-test disease odds to the pre-test disease odds. Since D( f || g) у 0, we have P in у 1. This is sensible, since a diagnostic test, if it contains any information to discriminate the diseased from the disease-free, would at least not make the presence of the disease less likely among the diseased subjects in the testing population. In other words, P in measures the 'increase' in disease odds of an average diseased subject. Whereas the P out is the ratio of the pre-test disease odds to the post-test disease odds for a randomly selected disease-free subject. Similarly, we have P out у 1. That is, P out measures the 'decrease' in disease odds of an average disease-free subject.
With these new performance indices, we can now have a better understanding of the rule-in and rule-out potentials of a diagnostic test. A diagnostic test with greater D( f || g) (and hence greater P in ), if administered, will on average make disease presence more likely among the diseased subjects in the testing population-its potential of ruling in disease is higher.
Whereas a diagnostic test with greater D( g || f ) (greater P out ), if administered, will on average make disease presence less likely among the disease-free and it has a higher rule-out potential. Naturally, a test with high potentials in both rule-in and ruleout abilities is most favourable. But in practice, we can select a test only good at either ruling in or ruling out disease to suit our specific need.
Examples
As a first example, consider two binary diagnostic tests: one test with Se = 0.8, Sp = 0.9 and the other with Se = 0.9, Sp = 0.8. These two tests have equal Youden's index (Youden's index = Se + Sp -1). 8 But their rule-in and rule-out potentials are different. The D( f || g) for the first test is 1.36, and is 1.15 for the second. And the D( g || f ) = 1.15 and 1.36, respectively. Therefore, we see that the first test (a more specific test) has higher rule-in potential, while the second one (a more sensitive test) performs better at ruling out disease. These conform to the 'rule in-specific test' and 'rule out-sensitive test' principle 1-4 as stated earlier.
We next consider the data presented in Swets' paper. 9 The data (Τable 1) consists of the rating results of a set of 708 mammograms (348 arising from malignant cases and 360 from benign cases). The rating is on a five-category scale of very likely benign, probably benign, possibly malignant, probably malignant, and very likely malignant. We also present in Table 1 the LR for the various rating results. These can be used to judge the rule-in/out potentials once the rating results are known. However, to understand how an average subject will turn out (the before-test potentials), we resort to the KullbackLeibler distances (D( f || g) = 0.71 and D( g || f ) =0.66). It becomes clear that a malignant case will be 2.03 times
.03) greater, on average, of being ruled in as malignant after performing the mammographic examination. While a benign case will become 1.93 times (P out = exp[D( g || f )] = 1.93) more likely to be benign. For a comparison, we also calculate the 'area under the receiver operating characteristic (ROC) curve' (AUC). 9 For this example, the AUC is found to be 0.79 (using trapezoidal rule 10 ). Unfortunately, the AUC is an overall index and does not differentiate the two different perspectives of diagnostic performances, that is, the potentials of ruling in and ruling out disease. Next, we present the rating results of two hypothetical diagnostic tests (A and B) for malignant breast cancers ( Table 2 ). The AUC of the A and the B tests are both 0.83 and are higher than that of the mammogram. Thus either the A or the B test is a sensible alternative to the conventional mammographic examination. But which one to choose? Unfortunately, the AUC index does not provide the answer since the values are the same for the two tests. Again, we resort to the Kullback-Leibler distances. For the D( f || g) index, we found that test A has a higher value than test B (1.13 Ͼ 0.85). While for the D( g || f ) index, the reverse is true (0.84 for test A and 1.10 for test B). This implies that test A has a greater potential for ruling in disease while test B performs better at ruling out disease. Thus, we may select test A or test B, depending on the purpose of the testing.
Finally, we show in Table 3 a 'binormal test' with ∆m = 1 and α = 5. 11 'Binormal' implies that the test results of both the diseased and the disease-free are normally distributed. The two parameters (∆m and α) describe their relative position. The ∆m measures the difference of the means of the two distributions in units of the standard deviation of the disease-free. And the α is the ratio of the standard deviations of the diseased to the disease-free. We see that this test has similar means but very different variances in the diseased and the disease-free groups. Although such tests may seem 'eccentric', tests of this kind are not uncommon. Somoza 11 reported that of the 28 diagnostic tests found in recent literature, three were found to be of this type. For ease of presentation, we assume the distribution of the disease-free to be the standard normal distribution and categorize the test results into 12 levels (р-2.5, -2.5 to -2.0, …, 2.0 to 2.5, Ͼ2.5). In Table 3 , we present the f i , g i , and the LR i for this test. We see that the test is quite unique in that its LR function is not monotonically increasing such as that of the breast mammogram in Table 1 . Further analysis shows that its ROC curve has portions that fall below the diagonal line (we omit the figure), resulting in a very small AUC value (AUC = 0.5772). Actually, the diagnostic performance of this test is far more than that. For this test, we found that D( f || g) = 2.2058 and D( g || f ) = 1.1203, which correspond to P in = 9.0776 and P out = 3.0659. Thus, we see that the test is quite useful in ruling in as well as ruling out disease. Table 4 shows the results of dichotomizing this 'non-monotone' test. Irrespective of the cutoff points chosen, we see that the dichotomized test now shows a much poorer performance. For this particular test, the common practice of dichotomizing a diagnostic test before clinical use should be avoided. b The distribution of the test results in disease-free subjects.
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c Likelihood ratio.
Discussion
In this paper, we see that the Kullback-Leibler distance, being weighted average of the log LR, integrates in a proper way two sources of information-the distribution of test outcomes and the LR function. The Kullback-Leibler distance measures the ability of a diagnostic test in revising disease probability (odds). This probability revision ability has two components-one for ruling in disease and one for ruling out. The index predicts the fate of an average subject before testing and offers us an opportunity to look at a test from a new perspective. Moreover, it works even when the conventional methods of dichotomization and ROC curve analysis fail to characterize the true performance of a test. The tests presented in Tables 2 and 3 are good examples. Two additional examples which also fail conventional methods can be found in recent papers. 12, 13 It is of interest to compare our approach to a formal costbenefit analysis. 14, 15 In a cost-benefit analysis, the relative costs and benefits associated with each test outcome are valued, and the expected utility of a diagnostic test is calculated. One then selects a test with maximum utility as his/her tool for diagnosing or screening disease. However, in many situations, the costs or benefits associated with various test outcomes are difficult or even impossible to estimate (e.g. what are the costs of missing a subject with neurotic depression in the community, or what are the benefits of early diagnosing a case of Huntington's disease?). It seems embarrassing that what seems to be a simple exercise of selecting a diagnostic test may sometimes become a daunting task. In fact, we don't really have to stick with the cost-andbenefit principle all the time. 16, 17 People may just want to be tested no matter what costs they have to pay, insofar as such an undertaking refines their disease odds. Further, physicians or epidemiologists may wish to initiate a test to reduce the uncertainty regarding disease status, even if the test has no strategic value (does not alter the treatment plan) at all. In these regards, the Kullback-Leibler distance, which measures the two aspects of probability revision potentials, seems a sensible alternative to the conventional cost-benefit analysis.
It is also of interest to compare the Kullback-Leibler distance to other measures which are also based on probability revision, such as 'entropy', [16] [17] [18] and 'Gini concentration', 18 as well as some scoring rules developed in the field of subjective probabilities. 19 These measures characterize diagnostic performances from different perspectives. However, the Kullback-Leibler distance is unique in several ways. First, it is based on disease odds but not directly on disease probability. This essentially makes it 'prevalence-free'. We note that the traditional indices of Se, Sp, LR, and the AUC do not depend on prevalence of disease, either. Secondly, the Kullback-Leibler distance can measure the two aspects of probability revision-rule in and rule out-each with clearly defined clinical role. By contrast, entropy, Gini concentration and scoring rules are aggregated measures. Finally, we wish to point out that the calculation of the Kullback-Leibler distance is the simplest among them all-it doesn't even require the calculation of the posterior probabilities. This confers an advantage for its widespread use. e Rule-in potential.
f Rule-out potential.
